Contaminated human breast milk is a major health concern for new moms that purchase donor breast milk. On October 21, I reported on a study in the journal Pediatrics that found that 72% of donor breast milk was contaminated with harmful bacteria and or viruses. I also noted that Prolacta, which produces human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU), would hold a grand opening event on Thursday, October 24, 2013, 4:00 p.m. (PDT), at their new facility in City of Industry, just 20 miles east of Los Angeles. Company representatives that human milk available at their new facility is subjected to rigorous safety standards.
Prolacta supplied me with the following information. It noted that it was not involved with nor do we promote milk sharing. Human milk that is exchanged through informal processes may not always be screened, tested nor pasteurized. Donors may not always be pre-screened or tested for viruses and drugs of abuse, which can be very dangerous to the recipient. Additionally, the FDA recommends against feeding your baby breast milk acquired directly from individuals or through the Internet.
Prolacta notes that it currently is the only organization that includes a rigorous donor qualification and milk collection process, a safety combination of DNA matching of mom to milk, testing for drugs and other contamination. Pooled donor milk is tested for HIV-1, HCV, and HBV using PCR tests to ensure the highest-quality available human milk products to feed the sickest infants in hospital NICUs. In addition, pooled milk, as well as finished product is tested for contamination, including specific tests for Salmonella and coliform bacteria including E. coli.
Prolacta officials note that they fully understand the danger that can be associated with tainted milk, and as such they have set the new standard of safety and quality in human milk collection, testing and processing. Prolacta’s milk processing is conducted in a pharmaceutical grade manufacturing facility that is the first and only of its kind worldwide. As a result, Prolacta is safely able to provide NICUs with a complete line of human milk formulations to meet the needs of critically ill premature infants.
For additional information about Prolacta, click on this link.